Published in Vaccine Weekly, November 8th, 2000
The contract will support the transition of new malaria vaccine candidates from discovery in the laboratory up to clinical trials.
Malaria claims one life every 30 seconds and sickens 300 million to 500 million people each year. It is the world's leading parasitic killer and second only to tuberculosis as an infectious cause...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2000-11-08)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.